Corporate Team

Ron wooten
Founding Partner

Ron Wooten, Founding Partner, of NovaQuest has over 25 years of healthcare investing experience is currently the CIO of NovaQuest Capital Management. He also heads the investment committee of the General Partner of NovaQuest Pharma Opportunities Fund III and IV. His responsibilities include management company oversight, investment policy, fundraising, and the day-to-day management of the NovaQuest Pharma Opportunities business.

Since its formation in 2000 through November 2010, while NQ was a business unit within Quintiles; Mr. Wooten led the platform in creating and managing unique relationships, structured finance and equity investments with more than $2 billion in gross commitments, capital or services to companies of all sizes. He was also an Executive Vice President of Quintiles and managed their customer-partnering arrangements worldwide. He also served on the Quintiles Board of Directors from January 2008 through November 2010.

Mr. Wooten’s previous experience includes nine years with First Union Securities, where he served as a Managing Director of Investment Banking focusing on M&A transactions across the middle market. Before he started his career in finance, he was a member of the New England Patriots football team from 1981 to 1990.

Mr. Wooten received his Bachelor’s degree in Chemistry from the University of North Carolina at Chapel Hill and earned an MBA from Boston University.

JOHN BRADLEY
Founding Partner

John Bradley, Founding Partner, has nearly 20 years of experience in the healthcare industry and 30 years of overall experience in finance. He served as Senior Vice President of the NovaQuest business unit of Quintiles. Mr. Bradley negotiated and complex structured transactions, managed asset portfolios and directed the day-to-day finances of NovaQuest. As Senior Vice President of Quintiles’ Corporate Development Group, he directed a number of strategic transactions in acquisitions, divestitures, joint ventures, strategic sourcing and debt issuances.

Prior to joining Quintiles in 1996 as a Vice President of Finance, Mr. Bradley led several smaller companies as Chief Financial Officer. He began his career as an analyst for Conoco, and held finance and area controller positions for RJR Nabisco and Ryder Systems.

Mr. Bradley earned a Bachelor’s degree in Business Administration and an MBA from Wake Forest University, and is licensed as a Certified Public Accountant in the State of North Carolina.

WILLIAM ROBB
Founding Partner

William Robb, Founding Partner, is a member of the investment committee of the General Partner of NovaQuest Pharma Opportunities Fund III and IV. He has over 20 years of experience in the global healthcare industry. From the formation of the NovaQuest unit at Quintiles in 2000 through 2010, Mr. Robb led or had material involvement in the structuring, negotiation and management of over $1.4 billion in product-based and company investments. These included investment commitments of between $30m – $450m into both private and global biopharmaceutical companies, and in many cases, investment syndicates.

From 1997–2000, Mr. Robb led strategic consulting engagements for multiple healthcare industry clients at The Wilkerson Group in New York. His previous experience also includes business strategy consulting for A.T. Kearney and the management of World Bank global development projects.

He graduated with honors from Princeton University and holds an MBA in finance and strategy from the Kellogg Graduate School of Management at Northwestern University.

JONATHAN TUNNICLIFFE
Founding Partner

Jonathan Tunnicliffe, Founding Partner, is a member of the investment committee of the General Partner of NovaQuest Pharma Opportunities Fund III and IV. He has over 25 years of experience in the global healthcare industry. From the formation of the NovaQuest unit at Quintiles in 2000 through 2010, Mr. Tunnicliffe led the due diligence for over $1.4 billion in product-based and company investments. These transactions ranged from $30m – $450m commitments to both private and leading public biopharmaceutical companies.

Mr. Tunnicliffe was previously a founding member and Director of Operations of a specialized clinical research organization, S-Cubed, where he led all operational functions. In Mr. Tunnicliffe’s earlier career, he was a medical statistician at SmithKline and French (now Glaxo SmithKline) and at the University of Sheffield.

Mr. Tunnicliffe has a Bachelor’s degree in Mathematical Statistics from the University of Liverpool, a Master of Science in Medical Statistics from the University of Newcastle-upon-Tyne and an MBA from Sheffield Hallam University.

ROBERT HESTER
Chief Financial Officer

Robert Hester, Chief Financial Officer, has over 25 years of experience in finance and over 10 years of experience in the healthcare industry. In addition to overseeing all aspects of finances, financial reporting, investor reporting and compliance, Mr. Hester also has extensive experience in accounting for co-investor and pharma transactions and is instrumental in providing accounting and tax structuring advice to the NovaQuest investment team on its structured investments.

Prior to joining NovaQuest, upon its formation in 2010, Mr. Hester served five years as Senior Finance Director for the NovaQuest and Corporate Development units at Quintiles. Previous experience includes director and controller positions in the medical software (Misys Healthcare) and restaurant industries plus five years in public accounting with KPMG working in both the audit and tax departments, serving clients in a wide variety of industries.

Mr. Hester graduated with honors from North Carolina State University earning a Bachelor of Arts in Accounting. He is licensed as a Certified Public Accountant in the state of North Carolina and is a member of the North Carolina Association of CPAs.

BRYAN MILLS
Vice President & Controller

Bryan Mills, Vice President and Controller, has over 16 years of finance and accounting experience, with the last 10 years focused on the global healthcare industry.  He manages the finance team and is responsible for financial accounting, valuations, tax compliance, financial reporting, investment tax structuring, information technology, and supporting investor relations and fundraising.

Prior to joining NovaQuest, upon its formation in 2010, Mr. Mills worked in finance for Quintiles Transnational Corp., in their NovaQuest division.  In that role, he was responsible for financial accounting, financial reporting, internal controls, special projects, and investment tax structuring.

Prior to Quintiles Transnational Corp., Mr. Mills worked for PricewaterhouseCoopers, LLP in their audit and assurance practice.  In that role, he was responsible for managing a portfolio of clients, project budgets, audit teams, client deadlines, and delivering high quality audit and assurance services to clients.

Mr. Mills received a BA in Accounting and a BA in Finance from the Darla Moore School of Business at the University of South Carolina.

GREG DODGE
General Counsel & Chief Compliance Officer

Greg Dodge, General Counsel and Chief Compliance Officer, oversees all legal and compliance related issues at NovaQuest. Prior to joining NovaQuest, Mr. Dodge was an associate at Proskauer Rose LLP in their private investment funds group, where he had a general corporate practice with an emphasis on representing private investment fund sponsors in structuring funds and portfolio investment activities as well as regulatory, compliance and operational matters.

Mr. Dodge received a B.S. in Business Administration from Wake Forest University and a J.D. from the University of Virginia School of Law.